Mutations or homozygous deletions of PTEN were shown in 36% of the GBM cases that were studied by McLendon et al. and 86% of the GBM harbored at least one genetic event in the receptor tyrosine kinase PI3K pathway (86). The gene discussed is NTRK1; the disease is glioblastoma.